@ Newsroom | SEBIO - Part 2

NCBiotech Portfolio Company G1 Therapeutics Raises $105M in IPO

Posted by on May 18, 2017 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – G1 Therapeutics, a clinical-stage oncology company, became a publicly traded entity today with a $105 million initial public offering of seven million shares of stock priced at $15 a share. The IPO also gives underwriters a 30-day window to buy up to 1,050,000 additional shares at the same $15 apiece. G1, a spinout from the University of North Carolina at Chapel Hill, is developing novel therapies that address significant unmet needs in people with various cancers. The North Carolina Biotechnology Center bootstrapped the company with $500,000 in loans in...

Read More

Local venture capital firm has $31M to invest in ag-tech startups

Posted by on May 17, 2017 in Newsroom | 0 comments

MEMPHIS, TN. – A Memphis-based venture capital fund announced the close of a $31 million fund focused on rural America. Innova announced the close of Innova Ag Innovation Fund IV, which will focus on early stage investments in rural America and work with national farm organizations and other partners to identify, enable and accelerate ag-tech companies with high growth potential. As part of the U.S. Department of Agriculture’s (USDA’s) Rural Business Investment Program, the fund has been certified and licensed to operate as a Rural Business Investment Company (RBIC). This...

Read More

Patheon Agrees to $5.2 Billion Acquisition by Thermo Fisher Scientific

Posted by on May 16, 2017 in Newsroom | 0 comments

DURHAM, N.C. – Patheon N.V., a global provider of pharmaceutical development and manufacturing services that has a large production facility in Greenville, will be acquired by Thermo Fisher Scientific in a deal worth about $5.2 billion. The board of directors of the two publicly traded companies approved the acquisition in which Thermo Fisher will acquire all of the issued and outstanding stock shares of Patheon for $35 per share in cash. The transaction represents a purchase price of about $7.2 billion before the assumption of about $2 billion in net debt by Thermo Fisher. “Over the...

Read More

Cantex Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Development for CX-02 in Recur

Posted by on May 2, 2017 in Newsroom | 0 comments

WESTON, FL. –  Cantex Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancers and other life-threatening disorders, today announced that dosing has been initiated in its Phase 2 clinical trial for CX-02, Cantex’s proprietary combination of disulfiram + copper (DSF-Cu), in recurrent glioblastoma. The trial’s principal investigator is Jiayi Huang, M.D., at Washington University School of Medicine in St. Louis. “Evidence found in pre-clinical studies has strongly indicated that...

Read More

What the Milken Institute Rankings Mean to Me (or Why We Do What We Do)

Posted by on Apr 28, 2017 in Newsroom | 0 comments

GAINESVILLE, FL. – The March for Science made front page news all over the United States as we celebrated Earth Day, but the profession of tech transfer marches in support of science every day — whether the media is watching or not. At the University of Florida Office of Technology Licensing, we like to think we make a difference for the #GatorGood, indeed, the greater global good, every time we help move a scientist’s discovery from the lab into the marketplace where it can make the world a better place. Last week, the Milken Institute released its newest ranking of the...

Read More

Alabama team seeks new life sciences markets in Europe

Posted by on Apr 26, 2017 in Newsroom | 0 comments

BIRMINGHAM, AL. – Alabama business and community leaders are in Europe the week of April 24, 2017, seeking new market opportunities for the state’s growing bioscience industry in Germany and Denmark. The 22-member delegation also is promoting the cutting-edge developments happening at research centers from Huntsville to Birmingham to Mobile and beyond, an effort to encourage new investment in the state as a gateway to the broader U.S. life sciences sector. Alabama Secretary of Commerce Greg Canfield is leading the trade mission, which kicked off Monday in Berlin with meetings at the...

Read More